Cisplatin Injection
Failed Impurities/Degradation Specifications.
411 recalls · Class II, newest first
Failed Impurities/Degradation Specifications.
cGMP violations
cGMP violations
cGMP violations
cGMP violations
cGMP violations
cGMP violations
cGMP violations
cGMP violations
CGMP violations
Crystallization
Defective Delivery System: The dip tube is clogged causing the spray not to work.
Presence of Foreign Tablets/Capsules: A Carbamazepine Extended-Release 400 mg tablet was found in a 1000-count bottle of Atorvastatin Calcium Tablets, USP 40 mg.
CGMP deviations
CGMP deviations
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Lack of Assurance of Sterility: The impacted lots may contain a breach in the tube seal.
Temperature abuse: Products exposed to improper temperature above drug label specifications.
cGMP Deviations: Temperature excursion
Incorrect/Undeclared Excipients: The inactive ingredients labeled on the product boxes and tubes are listed as "mineral oil , petrolatum ". The inactive ingredients in the actual product are polyethylene glycol 400 , polyethylene glycol 4000.
Lack of Assurance of Sterility
Failed Dissolution Specifications
Microbial Contamination of Non-Sterile Product
Subpotent Drug